Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Difficile”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05430269
What this trial is testing

Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients

Who this might be right for
Diarrhea Caused by DrugClostridium Difficile Infections
Charles University, Czech Republic 36
Not applicableUnknownNCT04259931
What this trial is testing

PROSPECTIVE STUDY OF PREDISPOSING FACTORS OF REFRACTARY Clostridium Difficile INFECTION. INFLUENCE OF THE GUT MICROBIOMA

Who this might be right for
Clostridium Difficile Infection
Hospital Universitario de Cabuenes 50
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Not applicableStudy completedNCT03107169
What this trial is testing

Treatment of Initial Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Universidad Autonoma de Nuevo Leon 10
Post-approval studies (Phase 4)Study completedNCT01901276
What this trial is testing

Effects of Gastric Acid on Colonic Microbiome

Who this might be right for
Clostridium Difficile
Daniel Freedberg, MD 14
Large-scale testing (Phase 3)Study completedNCT02179658
What this trial is testing

Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Who this might be right for
Clostridium Difficile
Astellas Pharma Inc 210
Post-approval studies (Phase 4)Study completedNCT01670149
What this trial is testing

Rifaximin for Preventing Relapse of Clostridium Associated Diarrhoea

Who this might be right for
Clostridium Difficile Infection
University of Nottingham 151
Not applicableUnknownNCT05715567
What this trial is testing

Re-EValuating the Inhibition of Stress Erosions (REVISE) - COVID-19 Cohort Study

Who this might be right for
COVID-19GastroIntestinal Bleeding
McMaster University 600
Not applicableActive Not RecruitingNCT05612672
What this trial is testing

Evaluation of GeoHAI Implementation

Who this might be right for
Clostridioides Difficile InfectionHealthcare Associated Infection
Ohio State University 25
Large-scale testing (Phase 3)Study completedNCT02254811
What this trial is testing

FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
University of Alberta 116
Not applicableLooking for participantsNCT06311006
What this trial is testing

Safety Registry of a Fecal Microbiota Transplant Cohort

Who this might be right for
Clostridium Difficile Infections
Assistance Publique - Hôpitaux de Paris 305
Post-approval studies (Phase 4)Study completedNCT04171817
What this trial is testing

Animal-Assisted Visitation Program Chlorhexidine Trial

Who this might be right for
Methicillin-resistant Staphylococcus AureusClostridium DifficilePseudomonas Aeruginosa
Johns Hopkins Bloomberg School of Public Health 45
Not applicableStudy completedNCT05008640
What this trial is testing

Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™

Who this might be right for
Urinary Tract InfectionsInfectious DiarrheaClostridium Difficile Infection+2 more
Toi Labs, Inc. 143
Large-scale testing (Phase 3)Ended earlyNCT00466635
What this trial is testing

Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Who this might be right for
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Genzyme, a Sanofi Company 65
Not applicableStudy completedNCT04675723
What this trial is testing

The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection

Who this might be right for
Clostridioides Difficile Infection
Mayo Clinic 52
Not applicableUnknownNCT02570477
What this trial is testing

FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment

Who this might be right for
Clostridium Difficile Infection
Chinese University of Hong Kong 30
Testing effectiveness (Phase 2)Ended earlyNCT03973697
What this trial is testing

Penn Microbiome Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Recurrent Clostridium Difficile Infection
University of Pennsylvania 9
Not applicableLooking for participantsNCT05739825
What this trial is testing

Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation

Who this might be right for
Clostridioides Difficile Infection Recurrence
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Not applicableNot Yet RecruitingNCT06708676
What this trial is testing

Washed Microbiota Transplantation in Solid Organ Transplantation

Who this might be right for
Solid Organ Transplant Complications
The Second Hospital of Nanjing Medical University 50
Testing effectiveness (Phase 2)Study completedNCT01085591
What this trial is testing

Study of CB-183,315 in Participants With Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 210
Next Page